U.S. Stocks Tumble as Iran Peace Deal Uncertainty Spooks Markets 
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal 
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide 
Middle East War Rattles Global Markets as Oil Tops $100 and Dollar Surges 
Air Canada Express Crash at LaGuardia: Controller Distracted by Prior Emergency 
Chinese Universities with PLA Ties Found Purchasing Restricted U.S. AI Chips Through Super Micro Servers 
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan 
Gold Prices Climb as Middle East Ceasefire Talks Stir Market Optimism 
Rio Tinto's Resolution Copper Mine: U.S. Smelting Challenges and Global Operations Update 
Unilever and Magnum Face Defamation Lawsuit Over Ben & Jerry's Board Chair Dismissal 
SK Hynix Eyes Up to $14 Billion U.S. IPO to Fund AI Chip Expansion 
Gold Prices Drop Amid Iran Peace Talk Uncertainty and Stronger Dollar 
Novartis to Acquire Biotech Firm Excellergy in $2 Billion Deal 
The four types of dementia most people don’t know exist 
Barry Callebaut has halted manufacturing operations at its Weize chocolate plant in Belgium as a precautionary measure while conducting its root cause analysis and risk assessment after detecting salmonella in a production lot.
The company identified lecithin as the source of the contamination.
All chocolate products manufactured at the facility since June 25 have been placed on hold.
After the analysis, the lines will be cleaned and sanitized before production can resume.
Barry Callebaut, which informed the Belgian food authorities (FAVV) about the incident, said that their robust food safety programs allowed them to identify lecithin as the source of the contamination quickly.
The company added that they are reaching out to all customers who may have received impacted products.
The news comes after Ferrero temporarily suspended production at its Arlon facility in Belgium after the site was linked to a salmonella outbreak.
